Company / Book Value per Share
Arcutis Biotherapeutics, Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.608
FY2025
5-year range
$1.279 / $6.025
FY2021-FY2025
Trend
-1.2%
vs FY2024
Sector context
#156 of 209
Health Care
What the data says
Arcutis Biotherapeutics, Inc.'s book value per share of $1.608 is lower than 75% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 8 years, ranging from -$35.28 in FY2019 to $7.587 in FY2020.
Based on SEC 10-K filings.
$1.608 in FY2025 with a 5-year CAGR of -26.7%.
Improved from $1.279 to $1.608 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -25.0%
- 5-Year CAGR
- -26.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 209This company $1.608 Sector average $215.686
▼
-99.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -26.7%, indicating a declining trend.
- In FY2025, book value per share decreased 1.2% year-over-year.
- Ranks #156 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.608 | -1.2% |
| FY2024 | $1.628 | +27.2% |
| FY2023 | $1.279 | -66.4% |
| FY2022 | $3.808 | -36.8% |
| FY2021 | $6.025 | -20.6% |
| FY2020 | $7.587 | +121.5% |
| FY2019 | -$35.28 | -82.3% |
| FY2018 | -$19.349 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026